Teng Y, Huang Y, Tao X, Fan Y, You J
Photochem Photobiol Sci. 2025; .
PMID: 40063311
DOI: 10.1007/s43630-025-00691-1.
Krisanti R, Wanandi S, Wuyung P, Hoemardani A
J Adv Vet Anim Res. 2025; 11(4):1105-1113.
PMID: 40013270
PMC: 11855443.
DOI: 10.5455/javar.2024.k861.
Baskaran S, Ravichandran J, Shree P, Thengumthottathil V, Karthikeyan B, Samal A
ACS Omega. 2025; 10(2):1927-1942.
PMID: 39866619
PMC: 11755174.
DOI: 10.1021/acsomega.4c06708.
Maggs L, McVey M
Front Oncol. 2025; 14:1516165.
PMID: 39839778
PMC: 11747621.
DOI: 10.3389/fonc.2024.1516165.
Gao F, Sun Y, Gan H
Arch Dermatol Res. 2024; 317(1):160.
PMID: 39738877
DOI: 10.1007/s00403-024-03657-y.
Quercetin as a therapeutic agent for skin problems: a systematic review and meta-analysis on antioxidant effects, oxidative stress, inflammation, wound healing, hyperpigmentation, aging, and skin cancer.
Okselni T, Septama A, Juliadmi D, Dewi R, Angelina M, Yuliani T
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39738831
DOI: 10.1007/s00210-024-03722-3.
Bio-Food Quality, Environmental Pollution, and the Role of Algae in Promoting Human Health and Sustainability.
Pruteanu L, Mare R, Mihalescu B, Jantschi L
Life (Basel). 2024; 14(11).
PMID: 39598311
PMC: 11596003.
DOI: 10.3390/life14111513.
Comparison of Microalgae and Lipid Extracts Effects on UVA-Induced Changes in Human Skin Fibroblasts Proteome.
Atalay Ekiner S, Gegotek A, Domingues P, Domingues M, Skrzydlewska E
Mar Drugs. 2024; 22(11).
PMID: 39590789
PMC: 11595653.
DOI: 10.3390/md22110509.
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm.
Dobre A, Nedelcu R, Turcu G, Brinzea A, Struna I, Tudorache G
Am J Clin Dermatol. 2024; 26(1):45-59.
PMID: 39572470
PMC: 11742465.
DOI: 10.1007/s40257-024-00900-0.
Langerhans cells orchestrate apoptosis of DNA-damaged keratinocytes upon high-dose UVB skin exposure.
Ortner D, Strandt H, Tripp C, Spoeck S, Seretis A, Hornsteiner F
Eur J Immunol. 2024; 54(12):e2451020.
PMID: 39288297
PMC: 11628926.
DOI: 10.1002/eji.202451020.
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review.
Hosseini T, Park S, Guo T
Cancers (Basel). 2024; 16(16).
PMID: 39199674
PMC: 11352924.
DOI: 10.3390/cancers16162904.
ASH1L guards cis-regulatory elements against cyclobutane pyrimidine dimer induction.
Yancoskie M, Khaleghi R, Gururajan A, Raghunathan A, Gupta A, Diethelm S
Nucleic Acids Res. 2024; 52(14):8254-8270.
PMID: 38884271
PMC: 11317172.
DOI: 10.1093/nar/gkae517.
Advancements in Dermatological Applications of Curcumin: Clinical Efficacy and Mechanistic Insights in the Management of Skin Disorders.
Mo Z, Yuan J, Guan X, Peng J
Clin Cosmet Investig Dermatol. 2024; 17:1083-1092.
PMID: 38765192
PMC: 11100965.
DOI: 10.2147/CCID.S467442.
Nanotechnology as a Promising Method in the Treatment of Skin Cancer.
Adamus-Grabicka A, Hikisz P, Sikora J
Int J Mol Sci. 2024; 25(4).
PMID: 38396841
PMC: 10889690.
DOI: 10.3390/ijms25042165.
Role of autophagy in skin photoaging: A narrative review.
Zhong X, Deng Y, Yang H, Du X, Liu P, Du Y
Medicine (Baltimore). 2024; 103(8):e37178.
PMID: 38394552
PMC: 11309671.
DOI: 10.1097/MD.0000000000037178.
High UV damage and low repair, but not cytosine deamination, stimulate mutation hotspots at ETS binding sites in melanoma.
Duan M, Song S, Wasserman H, Lee P, Liu K, Gordan R
Proc Natl Acad Sci U S A. 2024; 121(4):e2310854121.
PMID: 38241433
PMC: 10823218.
DOI: 10.1073/pnas.2310854121.
Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment.
Zhao C, Pan B, Wang T, Yang H, Vance D, Li X
Pharmaceutics. 2023; 15(12).
PMID: 38140070
PMC: 10747500.
DOI: 10.3390/pharmaceutics15122729.
The Ultraviolet Irradiation of Keratinocytes Induces Ectopic Expression of LINE-1 Retrotransposon Machinery and Leads to Cellular Senescence.
Touma F, Lambert M, Martinez Villarreal A, Gantchev J, Ramchatesingh B, Litvinov I
Biomedicines. 2023; 11(11).
PMID: 38002016
PMC: 10669206.
DOI: 10.3390/biomedicines11113017.
Human DNA Mutations and their Impact on Genetic Disorders.
Samir S
Recent Pat Biotechnol. 2023; 18(4):288-315.
PMID: 37936448
DOI: 10.2174/0118722083255081231020055309.
State of the Art of Pharmacological Activators of p53 in Ocular Malignancies.
Casciano F, Zauli E, Busin M, Caruso L, AlMesfer S, Al-Swailem S
Cancers (Basel). 2023; 15(14).
PMID: 37509256
PMC: 10377487.
DOI: 10.3390/cancers15143593.